Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.45 USD | -0.89% | -6.53% | -16.07% |
May. 30 | Sector Update: Health Care Stocks Higher in Afternoon Trading | MT |
May. 30 | INmune Bio to Join Russell 3000 Index in July | MT |
Financials (USD)
Sales 2024 * | 28K | Sales 2025 * | 29K | Capitalization | 187M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -51M | EV / Sales 2024 * | 6,677 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 6,446 x |
P/E ratio 2024 * |
-3.51
x | P/E ratio 2025 * |
-3.7
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.84% |
Latest transcript on INmune Bio, Inc.
1 day | -0.89% | ||
1 week | -6.53% | ||
1 month | -20.19% | ||
3 months | -18.53% | ||
Current year | -16.07% |
Managers | Title | Age | Since |
---|---|---|---|
David Moss
FOU | Founder | 54 | 15-08-31 |
Mark Lowdell
FOU | Founder | 61 | 15-08-31 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcia Allen
BRD | Director/Board Member | 73 | 19-11-18 |
Raymond Tesi
CEO | Chief Executive Officer | 68 | 15-08-31 |
Scott Juda
BRD | Director/Board Member | 53 | 18-03-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 9.45 | -0.89% | 61,224 |
24-05-30 | 9.535 | -1.19% | 66,338 |
24-05-29 | 9.65 | -4.93% | 68,087 |
24-05-28 | 10.15 | +0.40% | 83,390 |
24-05-24 | 10.11 | -0.10% | 65,492 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.07% | 187M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- INMB Stock